자가포식현상과 신경퇴행병
Autophagy and Neurodegenerative Diseases
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Autophagy is a highly regulated cellular mechanism that results in the bulk degradation of long-lived proteins and organelles and which seems to be implicated in a variety of physiological and pathological conditions relevant to neurological diseases. The formation of intraneuronal mutant protein aggregates is a characteristic of several human neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease, and polyglutamine disorders such as Huntington’s disease (HD). Autophagy is a major clearance pathway for the removal of the mutant huntingtin protein associated with HD, and many other disease-causing, cytoplasmic, aggregate-prone proteins. Autophagy is negatively regulated by the mammalian target of rapamycin (mTOR) and can be induced in all mammalian cell types by the mTOR inhibitor rapamycin. It can also be induced by an mTOR-independent pathway, which has multiple drug targets, involving links between Ca2+-calpain–Gsα and cAMP–Epac–PLC-e–IP3 signaling. Both pathways enhance the process of autophagy. In this review, we describe the various drugs and pathways that induce autophagy that are potential therapeutic approaches for neurodegenerative disorders.
Abstract
Autophagy is a highly regulated cellular mechanism that results in the bulk degradation of long-lived proteins and organelles and which seems to be implicated in a variety of physiological and pathological conditions relevant to neurological diseases. The formation of intraneuronal mutant protein aggregates is a characteristic of several human neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease, and polyglutamine disorders such as Huntington’s disease (HD). Autophagy is a major clearance pathway for the removal of the mutant huntingtin protein associated with HD, and many other disease-causing, cytoplasmic, aggregate-prone proteins. Autophagy is negatively regulated by the mammalian target of rapamycin (mTOR) and can be induced in all mammalian cell types by the mTOR inhibitor rapamycin. It can also be induced by an mTOR-independent pathway, which has multiple drug targets, involving links between Ca2+-calpain–Gsα and cAMP–Epac–PLC-e–IP3 signaling. Both pathways enhance the process of autophagy. In this review, we describe the various drugs and pathways that induce autophagy that are potential therapeutic approaches for neurodegenerative disorders.
참고문헌 (41)
- Mizushima N, "Autophagy fights disease through cellular self-digestion", Nature, 451, pp.1069~1075 (2008)
- Saftig P, "Live longer with LAMP-2", Nat Med, 14, pp.909~910 (2008)
- Kroemer G, "Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009", Cell Death Differ, 16, pp.3~11 (2009)
- Huang J, "Autophagy and human disease", Cell cycle, 6, pp.1837~1849 (2007)
- Massey AC, "Chaperone-mediated autophagy in aging and disease", Curr Top Dev Biol, 73, pp.205~235 (2006)
- Cuervo AM, "Age-related decline in chaperone-mediated autophagy", J Biol Chem, 275, pp.31505~31513 (2000)
- Cuervo AM, "Autophagy and aging: the importance of maintaining “clean” cells", Autophagy, 1, pp.131~140 (2005)
- Scarlatti F, "Does autophagy have a license to kill mammalian cells?", Cell Death Differ, 16, pp.12~20 (2009)
- Yorimitsu T, "Autophagy: molecular machinery for selfeating", Cell Death Differ, 12, pp.1542~1552 (2005)
- Levine B, "Development by self-digestion: molecular mechanisms and biological functions of autophagy", Dev Cell, 6, pp.463~477 (2004)
- Vellai T, "Autophagy genes and ageing", Cell Death Differ, 16, pp.94~102 (2009)
- Zhang C, "Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function", Nat Med, 14, pp.959~965 (2008)
- Klionsky DJ, "A unified nomenclature for yeast autophagy-realted genes", Dev Cell, 5, pp.539~545 (2003)
- Geng J, "The Atg8 and Atg12 ubiquitin-like conjugation systems in macrophagy. ‘Protein modifications: beyond the usual suspects’ review series", EMBO Rep, 9, pp.859~864 (2008)
- Barth H, "A genomic screen identifies AUT8 as a novel gene essential for autophagy in the yeast Saccharomyces cerevisiae", Gene, 274, pp.151~156 (2001)
- Barth H, "Autophagy and the cytoplasm to vacuole targeting pathway both require Aut10p", FEBS Lett, 508, pp.23~28 (2001)
- Funakoshi T, "Analysis of APG13 gene involved in autophagy in yeast, Saccharomyces Cerevisiae", Gene, 192, pp.207~213 (1997)
- Lang T, "Aut2p and Aut7p, two novel microtubule associated proteins are essential for delivery of autophagic vesicles to the vacuole", EMBO J, 17, pp.3597~3607 (1998)
- Liang XH, "Induction if autophagy and inhibition og tumorigenesis by beclin 1", Nature, 402, pp.672~676 (1999)
- Hara T, "Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice", Nature, 441, pp.885~889 (2006)
- Berger Z, "Rapamycin alleviates toxicity of different aggregate-prone proteins", Hum Mol Genet, 15, pp.433~442 (2006)
- Ravikumar B, "Rapamycin pre-treatment protects against apoptosis", Hum Mol Genet, 15, pp.1209~1216 (2006)
- Ravikumar B, "Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy", Hum Mol Genet, 12, pp.985~994 (2003)
- Sarkar S, "A rational mechanism for combination treatment of Huntington’s disease using lithium and rapamycin", Hum Mol Genet, 17, pp.170~178 (2008)
- Williams A, "Novel targets for Huntingtin’s disease in an mTOR-independent autophagy pathway", Nat Chem Biol, 4, pp.295~305 (2008)
- Sarkar S, "Trehalose, a novel mTOR independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein", J Biol Chem, 282, pp.5641~5652 (2007)
- Tanaka M, "Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease", Nat Med, 10, pp.148~154 (2004)
- Sarbassov DD, "Growing roles for the mTOR pathway", Curr Opin Cell Biol, 17, pp.596~603 (2005)
- Kim DH, "mTOR interacts with raptor to form a nutrientsensitive complex that signals to the cell growth machinery", Cell, 110, pp.163~175 (2002)
- Kim DH, "GbetaL, a positive regulator of the rapamycinsensitive pathway required for the nutrient sensitive interaction between raptor and mTOR", Mol Cell, 11, pp.895~904 (2003)
- King MA, "Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis", Mol Pharmacol, 73, pp.1052~1063 (2008)
- Varadarajan N, "An engineered protease that cleaves specifically after sulfated tyrosine", Angew Chem Int Ed Eng, 47, pp.7861~7863 (2008)
- Vecsey CG, "Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB: CBP-dependent transcriptional activation", J Neurosci, 27, pp.6128~6140 (2007)
- Pandey UB, "HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS", Nature, 447, pp.859~863 (2007)
- Sarkar S, "Lithium induces autophagy by inhibiting inositol monophosphatase", J Cell Biol, 170, pp.1101~1111 (2005)
- Zhang L, "Small molecule regulators of autophagy identified by an image-based high-throughput screen", Proc Natl Acad Sci USA, 104, pp.19023~19028 (2007)
- Sarkar S, "Small molecules enhance autophagy and reduce toxicity in Huntington’s disease models", Nat Chem Biol, 3, pp.331~338 (2007)
- Berridge MJ, "Inositol trisphosphate and calcium signalling", Nature, 361, pp.315~325 (1993)
- Criollo A, "Regulation of autophagy by the inositol trisphosphate receptor", Cell Death Differ, 14, pp.1029~1039 (2007)
- Sarkar S, "Inositol and IP3 levels regulate autophagy: biology and therapeutic speculations", Autophagy, 2, pp.132~134 (2006)
- Thomas RS, "An antibody to the beta-secretase cleavage site on amyloid-beta-protein precursor inhibits amyloid-beta production", J Alzheimers Dis, 10, pp.379~390 (2006)